We are live on ! Find out more
CPHR

Cipher Pharmaceuticals Inc.
CPHR

Delisted

CPHR was delisted on the 8th of December, 2016.

Back to rankings

Fund managers haven’t disclosed any holdings of CPHR yet.

CPHR Hedge Fund Activity: Q3 2017 in Review

0 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Cipher Pharmaceuticals Inc. (CPHR) for Q3 2017, worth a combined $0 — down 100% from $8.53M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of CPHR and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Grandeur Peak Global Advisors, exiting entirely with an estimated $8.53M sold.

  • 0 institutional investors held Cipher Pharmaceuticals Inc. (CPHR) as of Q3 2017, down from 1 in Q2 2017.
  • Funds reported $0 of Cipher Pharmaceuticals Inc. stock for Q3 2017, down 100% quarter-over-quarter.
  • 0 funds opened new Cipher Pharmaceuticals Inc. positions in Q3 2017 and 1 closed out, a net change of -1 holder.
  • The largest Cipher Pharmaceuticals Inc. seller in Q3 2017 was Grandeur Peak Global Advisors, an estimated $8.53M sold.

Based on aggregated 13F filings for Q3 2017.